Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Frontiers in Cell and Developmental Biology|June 2, 2022
Research Progress on Mono-ADP-Ribosyltransferases in Human Cell BiologyYujie Gan, Huanhuan Sha, Renrui Zou, et al.Mediators of Inflammation|March 19, 2020
The Mast Cell Is an Early Activator of Lipopolysaccharide-Induced Neuroinflammation and Blood-Brain Barrier Dysfunction in the HippocampusYiwei Wang, Huanhuan Sha, Leting Zhou, et al.Cancer Medicine|October 21, 2022
NBDHEX re-sensitizes adriamycin-resistant breast cancer by inhibiting glutathione S-transferase piHuanhuan Sha, Renrui Zou, Ya Lu, et al.Heliyon|November 29, 2023
A case report: A new promising treatment for pulmonary sarcomatoid carcinoma - Tislelizumab and Anlotinib combined with local radiotherapyRuoxue Cai, Ying Liu, Huanhuan Sha, et al.American Journal of Translational Research|November 16, 2020
Lipid metabolism-related proteins of relevant evolutionary and lymphoid interest (PRELI) domain containing family proteins in cancerYue Zhu, Renrui Zou, Huanhuan Sha, et al.Journal of Cancer Research and Clinical Oncology|June 1, 2023
To be, or not to be: the dilemma of immunotherapy for non-small cell lung cancer harboring various driver mutationsRuoxue Cai, Hongyu Zhu, Ying Liu, et al.Human Vaccines & Immunotherapeutics|November 4, 2024
Efficacy of rechallenge after first-line immunotherapy for advanced gastric cancer: A retrospective real-world studyMengya Guo, Wenhui Zhao, Yue Chen, et al.Cancer Cell International|May 22, 2020
CRNDE: an oncogenic long non-coding RNA in cancersYa Lu, Huanhuan Sha, Xun Sun, et al.Cancer Immunology, Immunotherapy : CII|November 1, 2023
A retrospective real-world study: the efficacy of immune-related combination therapies in advanced non-small cell lung cancer after resistance to EGFR-TKIsRuoxue Cai, Ying Liu, Mingyan Yu, et al.Oncology Letters|January 25, 2019
Circulating tumor DNA detection: A potential tool for colorectal cancer managementHuizi Li, Changwen Jing, Jianzhong Wu, et al.Pageof 3